Skip to search formSkip to main contentSkip to account menu

Clavulanate

Known as: Clavulanate [Chemical/Ingredient], Clavulansäure 
National Institutes of Health

Related topics

Related topics

18 relations
Amoxicillin / ClavulanateCholestasis, ExtrahepaticClavulanate / TicarcillinClavulanate Ab.IgE:ACnc:Pt:Ser:Qn

Narrower (4)

AugmentinClavamoxTimentinclavulanate potassium

Broader (2)

Clavulanic AcidClavulanic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms.
BACKGROUND BAL30376 combines the siderophore monobactam BAL19764 (Syn/PTX 2416) with the bridged monobactam BAL29880 to inhibit… 
2008
2008
Reaction of rat connective tissue to a new calcium hydroxide-based sealer.
2004
2004
Evaluation of penicillin-based inhibitors of the class A and B beta-lactamases from Bacillus anthracis.
2002
2002
Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Review
2001
Review
2001
Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.
Highly Cited
1999
Highly Cited
1999
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains.
1995
1995
beta-Lactamase mutations far from the active site influence inhibitor binding.
Highly Cited
1986
Highly Cited
1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic…
The in vitro synergistic activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam, combined with… 
Highly Cited
1986
Highly Cited
1986
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes
The in vitro activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with six beta-lactams… 
1986
1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)